FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 88 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $265,000 | +48.9% | 56,422 | -28.2% | 0.04% | -2.2% |
Q1 2020 | $178,000 | -61.6% | 78,534 | -22.1% | 0.04% | -16.7% |
Q4 2019 | $463,000 | +332.7% | 100,876 | +265.1% | 0.05% | +285.7% |
Q3 2019 | $107,000 | -10.1% | 27,626 | +39.8% | 0.01% | +7.7% |
Q2 2019 | $119,000 | -72.1% | 19,767 | -35.4% | 0.01% | -45.8% |
Q3 2018 | $426,000 | -26.7% | 30,600 | -9.5% | 0.02% | -22.6% |
Q1 2018 | $581,000 | -29.8% | 33,800 | +22.9% | 0.03% | -42.6% |
Q2 2017 | $828,000 | -48.1% | 27,500 | -37.6% | 0.05% | -37.2% |
Q1 2017 | $1,594,000 | -56.0% | 44,100 | -39.0% | 0.09% | -60.4% |
Q4 2016 | $3,622,000 | -2.8% | 72,279 | +1.8% | 0.22% | +8.5% |
Q3 2016 | $3,727,000 | -4.5% | 71,000 | -24.8% | 0.20% | -7.4% |
Q2 2016 | $3,904,000 | +5.7% | 94,425 | +3.9% | 0.22% | -8.1% |
Q1 2016 | $3,692,000 | +23.2% | 90,862 | +25.8% | 0.24% | +59.9% |
Q4 2015 | $2,996,000 | +199.0% | 72,200 | +10.9% | 0.15% | +200.0% |
Q3 2015 | $1,002,000 | +235.1% | 65,114 | +441.3% | 0.05% | +345.5% |
Q2 2015 | $299,000 | -66.4% | 12,029 | -69.1% | 0.01% | -68.6% |
Q1 2015 | $889,000 | – | 38,896 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |